Flubrotizolam presents itself as a novel benzodiazepine derivative. Introduced for limited purposes, flubrotizolam possesses remarkable hypnotic effects. Its chemical properties reveal a high affinity for the GABA receptor, producing significant CNS suppression. Although its potential pharmaceutical applications, flubrotizolam's illicit use has sur